Abstract:
A skin sample culture apparatus is disclosed, which uses a culture medium to maintain the viability of the sample and comprises means for maintaining the sample under tension. In an embodiment the apparatus (171) has a base (173), a securing member (175) and a tensioner cap (177). The skin sample (183) is placed between the base and securing member. Through holes (187) in the securing member are aligned with holes (174) in the base, and screws or other suitable fixings are tightened to secure the skin sample in position. Tension adjustment is provided by the cap, which is positioned on top of the securing member and has a tension adjustment mechanism (179) comprising a screw (195) extending through the cap into the securing member, wherein tightening of the screw increases the tension across the sample.
Abstract:
A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
Abstract:
A method for welding together glass workpieces where one of the workpieces has metal nanoparticles positioned at or near the surface to be welded. The method comprises positioning the workpieces in operative contact at an interface where a weld is to be formed, applying a laser beam to be incident upon the interface wherein energy from the laser beam is absorbed by the nanoparticle bearing workpiece and the energy from the laser beam is transferred to the glass surrounding the metal nanoparticles to heat the glass and to weld the workpieces together.
Abstract:
According to the present invention, there is provided an apparatus for mineralising a biological material, the apparatus comprising an ultrasonic source, operable to generate an ultrasonic signal, an ultrasonic probe and one or more mineralising probes, operable to receive a mineralising agent, wherein the mineralising agent is transferred from at least one mineralising probe to the biological material using the ultrasonic signal. There is also provided a mineralisation agent and a method of mineralising a biological material, said method comprising the steps of: providing an ultrasound source, providing a mineralising agent, generating an ultrasonic signal from the ultrasound source, applying the ultrasonic signal and the mineralising agent to the biological material separately, sequentially or simultaneously.
Abstract:
A multi-component admixture containing a surfactant which is adapted to provide an interface between hydrophobic toner particles and a hydrophilic cement-based or gypsum-based mix such as concrete or plaster to facilitate homogeneous mixing of the two materials.
Abstract:
An optical system (31) with an input optical source (33) for projecting an input beam along an optical axis and an optical element (37, 43) which creates a cone refracted beam (41) from the input beam (35) then reconstructs the input beam (49). The optical element may comprise a first cone refractive element (37) which creates a cone refracted beam and reconstructs the beam using a reconstructing optical element (43) to apply a phase shift to the cone refracted beam. The optical system may be used to form a laser or a gain medium for a laser.
Abstract:
Non-human animals which overexpress PPARd or which express transgenic PPARd are useful as models for inflammatory skin conditions such as psoriasis. Test substances can be screened to assess their suitability for the treatment of inflammatory skin conditions such as psoriasis. Methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate can be administered topically for the prevention or treatment of psoriasis.
Abstract:
We disclose agents useful in the treatment of diseases or conditions that would benefit from improved muscle function and including pharmaceutical compositions and diagnostic tests for determining the predisposition of a subject, in particular a male subject, to cardiovascular disease.
Abstract:
The present invention relates to specific compounds for use in controlling inflammatory cell function and their potential use in modulating an immune response or inflammation. The present invention also relates to the identification of an alternative RSK pathway in, for example, dendritic cells and the development of assays for the identification of compounds capable of modulating the alternative RSK associated pathway in dendritic cells/macrophage cells and their potential use in enhancing, or controlling an immune response or in treating inflammation.
Abstract:
The present invention relates to the use of certain pyrimidine compounds to inhibit, for example, TBKl and/or IKK epsilon and which may therefore find application in treating cancer septic shock and/or Primary open Angle Glaucoma (POAG).